about
Identifying HIV-1 dual infectionsRetroviral superinfection resistance.Analysis of HIV-1 protease gene reveals frequent multiple infections followed by recombination among drug treated individuals living in São Paulo and Santos, BrazilOverview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.HIV/AIDS epidemiology, pathogenesis, prevention, and treatmentChronic HIV-1 infection frequently fails to protect against superinfectionThe context of HIV risk behaviours among HIV-positive injection drug users in Viet Nam: moving toward effective harm reductionHIV-1 superinfection in the antiretroviral therapy era: are seroconcordant sexual partners at risk?HIV-1 subtypes and recombinants in Northern Tanzania: distribution of viral quasispecies.Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in UgandaImpact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.Extensive intrasubtype recombination in South African human immunodeficiency virus type 1 subtype C infections.Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses.Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trial.Pharmacotherapy, vaccines and malaria advice for HIV-infected travellers.Frequency of subtype B and F1 dual infection in HIV-1 positive, Brazilian men who have sex with men.Worldwide molecular epidemiology of HIV.Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate.Frequency and implications of HIV superinfection.Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men.Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United States.Dynamical properties and thresholds of an HIV model with super-infection.First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar.Longitudinal HIV-1 gp120-C2V3C3 phylogenetic surveillance and tropism evolution in patients under HAART.Immunological and virological characteristics of human immunodeficiency virus type 1 superinfection: implications in vaccine design.
P2860
Q22241756-D88EDE64-0E46-4B75-9CCB-AEF54F2BEF91Q24815564-DFCAFF43-086B-4C4A-A759-1829D89A5B88Q28538304-C67BF5A2-8459-4637-948A-AC8609150E48Q30249677-EBDC92F7-E01C-4F65-A410-0565128B7D7DQ30356074-1E89E4D9-DF50-4C66-8480-7D9AE0033D1FQ33306107-8836BBB7-38FD-4BA7-84F8-579A5960C69DQ33427206-5217650E-DE9A-437B-B881-F53303CBA01AQ33455743-46CE3033-4D56-41F6-81B5-2A16FEAF8F7BQ34464538-0FEF9C4D-DC22-4905-9819-837C81BF3AB8Q34587037-D44DA649-4784-4B11-992C-1A197E185837Q34593647-0ED1669D-AC6B-4202-9603-81565F038918Q35857346-CC2BC940-28A6-40C8-BABA-E4BD701252DCQ35950936-129E2641-F351-4150-950E-4AF2FA902FCFQ35998938-6B10E81B-62C9-493F-9C1E-F27DD11C40E6Q36161252-70353329-4889-46D1-BDDF-4D3D552AF844Q36402861-BFA4B5CB-EBD6-46D9-A70F-AFA178E1FB2AQ36438805-F658418D-5F79-42CE-AE3C-33DC1E2B5584Q36994644-05ED9CE2-A01C-449C-AD85-C74D30AFF860Q37110714-B977E4BA-92DD-4F44-8A3D-307ADB2EED73Q37118973-49C47E02-EE35-452F-9F0E-1D7437B9A499Q37253688-F9412169-07FA-47EE-8342-BD5873B4A1B2Q37635156-29155B9B-376C-4592-AF0B-2AB33976F883Q39208948-ED22009B-B56C-49D3-9CE5-25DBB12F9AA4Q40602269-F964EFFF-AF41-4AB8-BB89-F935728AC9C6Q44592371-A67EF006-4A2E-49D2-ACD5-0A83BBCC8C4EQ45324321-49A007CE-2915-4553-BB72-B4037AA84B53
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
HIV-1 co/super-infection in intravenous drug users.
@en
HIV-1 co/super-infection in intravenous drug users.
@nl
type
label
HIV-1 co/super-infection in intravenous drug users.
@en
HIV-1 co/super-infection in intravenous drug users.
@nl
prefLabel
HIV-1 co/super-infection in intravenous drug users.
@en
HIV-1 co/super-infection in intravenous drug users.
@nl
P2093
P50
P1433
P1476
HIV-1 co/super-infection in intravenous drug users.
@en
P2093
Amalio Telenti
Jean-Phillppe Chave
Laurent Kaiser
Luc Perrin
Martine Monnat
Philippe Burgisser
Stéphanie Jost
P304
P356
10.1097/01.AIDS.0000131330.28762.0C
P407
P577
2004-07-01T00:00:00Z